Sachin Shah Expects Sanofi-Genzyme Accord by Wednesday: Video

Feb. 7 (Bloomberg) -- Sachin Shah, a special situations and merger arbitrage strategist at Capsto...  More »

Feb. 7 (Bloomberg) -- Sachin Shah, a special situations and merger arbitrage strategist at Capstone Global Markets LLC, talks about Sanofi-Aventis SA's $19.2 billion takeover offer for Genzyme Corp. and the outlook for mergers and acquisitions this year. Shah speaks with Erik Schatzker on Bloomberg Television's "InsideTrack." (Source: Bloomberg)  « Less